Published in Cardiovascular Business Week, March 28th, 2006
A biopharmaceutical company with offices in Cleveland Clinic's Innovation Center, Minnesota, and California, Symphony will use the funding to increase its staff size, complete clinical trials, and introduce a new product in Europe aimed at preventing atrial fibrillation after surgery.
The company's latest financing round included a new investor, Triathlon Medical Ventures, and existing investors, Morgehnthaler Ventures, Domain Associates, and Guidant Compass Group....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.